Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

NCT05156398 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

640

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Rimegepant
DRUG: Placebo

Sponsor

Pfizer